13/06/2005
ReGen Therapeutics Plc (the ‘Company’) announces that on 10 June 2005 it received notification from Dr P. Garrod, a non-executive director, that he had acquired 1,000,000 ordinary shares of the Company at 1.25p per share. Dr Garrod now holds and is beneficially interested in 38,750,000 ordinary shares representing 11.3% of the current issued share capital of the Company.
For further information, please contact:
Andrew Marshall
Marshall Robinson Roe
Tel. 020 7960 6007